Abstract
Regurgitation is a symptom most often described as the effortless return of material from the stomach to esophagus. It is commonly associated with gastroesophageal reflux disease but can come from many other disorders in the upper aerodigestive tract and stomach. Clinical history and selected testing can usually elucidate the cause of regurgitation. Common tests can include barium X-rays, esophageal manometry, and endoscopy. This chapter presents a suggested approach to patients presenting with this common symptom. Therapy for regurgitation relies on identifying and addressing the underlying pathophysiology of the symptom.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Klauser AG, Schindbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;135:205–8.
Boudewijn F, Bredenoord AJ, Smoot AJPM. Erroneous diagnosis of gastroesophageal reflux disease in achalasia. Clin Gastroenterol Hepatol. 2011;9:1020–4.
Absah I, Rishi A, Talley NJ, et al. Rumination syndrome: pathophysiology, diagnosis and treatment. Neurogastroenterol Motil 2017;29:e12954
Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenerology. 1987;93:1393–7.
Moayyedi P, Talley NJ, Fennerty MB, et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006;295:1566–76.
Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518–27.
Inadomi JM, McIntyre L, Bernard L, et al. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol. 2003;98:1940–4.
D’Alessandro A, Zito FP, Pesce M, Andreozzi P, et al. Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease. United European Gastroenterol J. 2016;5:54–9.
Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol. 2011;106:1419–25.
El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010;32:720–37.
Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–91.
Kahrilas PJ. When proton pump inhibitors fail. Clin Gastroenterol Hepatol. 2008;6:482–3.
Brendenoord AJ, Weusten BLAM, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut. 2006;55:313–8.
Kaul B, Petersen H, Grette K, Myrvold HE. Re-producibility of gastroesophageal reflux scintigraphy and the standard acid reflux test. Scand J Gastroenterol. 1986;21:795–8.
Richter JE, Pandolfino JE, Vela MF, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013;26:755–65.
Tutuian R, Vela MF, Hill EG, et al. Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol. 2008;103:1090e6.
Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100:283–9.
DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med. 1995;155:2165–73.
Vela M, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003;17:243–51.
Blondeau K, Boecxstaens V, Rommel N, et al. Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. Clin Gastroenterol Hepatol. 2012;10:379. -84
Boeckxstaens GE, Beaumont H, Hatlebakk JG, et al. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Gut. 2011;60:1182–8.
Vakil NB, Huff FJ, Bian A, Jones DS, Stamler D. Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol. 2011;106:1427–38.
Reimer C, Ng B, Smith G, et al. Concentrated alginate as add-on therapy in gastro-esophageal reflux disease patients with inadequate response to once daily proton pump inhibitor: a multicenter, randomized, double-blind, placebo-controlled pilot study. Gastroenterology. 1995;148:S135–6.
Antoniou SA, Delivorias P, Antoniou GA, et al. Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease – a prospective study. Langenbeck's Arch Surg. 2008;393:979–84.
Brillantino A, Schettino M, Torelli F, et al. Laparoscopic Nissen-Rossetti fundoplication is a safe and effective treatment for both acid and bile gastroesophageal reflux in patients poorly responsive to proton pump inhibitor. Surg Innov. 2011;18:387–93.
Broeders JA, Rijnhart-de Jong HG, et al. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial. Ann Surg. 2009;250:698–706.
Hamdy E, Nakeeb AE, Hamed H, et al. Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors. J Gastrointest Surg. 2014;18:1557–62.
Llang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterol. 2014;14:178.
Hunter JG, Kahrilas PJ, Bell RCW, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324–33.
Ganz RA, Edmundowicz SA, Taiganides PA, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016;14:671–7.
Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.
Malcolm A, Thumshim MB, Camilleri M, Williams DE. Rumination syndrome. Mayo Clin Proceed. 1997;72:646–52.
Stanghellin V, Chan FKL, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–92.
Anderson KO, Dalton CB, Bradley LA, Richter JE. Stress induces alteration of esophageal pressures in healthy volunteers and non-cardiac chest pain patients. Dig Dis Sci. 1989;34:83–91.
Nagahara A, Miwa H, Hojo M, et al. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastroesophageal reflux disease. J Clin Gastroenterol. 2006;40:891–5.
Fass R, Nailboff BD, Fass SS, et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008;134:696–705.
Schey R, Dickman R, Parthasarathy S, et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:1787–95.
Ott DJ, Wu WC, Gelfand DW. Reflux esophagitis revisited: prospective analysis of radiological accuracy. Gastrointest Radiol. 1981;6:1–7.
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–74.
Ratuapli SK, Crowell MD, DiBaise JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.
Bortolotti M, Mari C, Giovannini M, et al. Effects of sildenafil on esophageal motility of normal subjects. Dig Dis Sci. 2001;46:2301–6.
Kessing BF, Bredenoord AJ, Smout AJ. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol. 2014;109:52. -9
Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103:753–63.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.
Dellon ES, Speck O, Woodward K, et al. Clincial and endoscopic characteristics do not reliably differentiate PPI-response esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective, cohort study. Am J Gastroenterol. 2013;108:1854–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
DeVault, K.R. (2018). Regurgitation. In: Bardan, E., Shaker, R. (eds) Gastrointestinal Motility Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-59352-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-59352-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59350-0
Online ISBN: 978-3-319-59352-4
eBook Packages: MedicineMedicine (R0)